Dec. 12, 2025
J&J, plaintiffs clash in closings of first talc bellwether trial
Closing arguments in the long-running talc litigation featured competing expert testimony on asbestos detection, epidemiology and causation, leaving jurors to decide whether J&J's baby powder and "Shower to Shower" products were a substantial factor in two women's ovarian cancers.
Los Angeles jurors were told Friday that Johnson & Johnson used its multinational status and resources to "control the story" over the past four weeks about the safety of its talcum powder products.
The company's attorneys at Kirkland & Ellis LLP countered that no reliable scientific evidence shows the disputed baby and body powder products were substantial factors in causing the plaintiffs' "rare ovarian cancers."
During more than two...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In